MitoxantroneSolutionsWaterPharmaceutical SolutionsMagnetic Resonance SpectroscopyAnthraquinonesGuanidineHydrogen-Ion ConcentrationAntineoplastic AgentsCytarabineCircular DichroismAntineoplastic Combined Chemotherapy ProtocolsDrug StabilityATP-Binding Cassette TransportersTrimethylsilyl CompoundsKineticsModels, MolecularMolecular StructureMicellesProtein ConformationSolubilitySolventsDrug Resistance, MultipleAdsorptionSpectrophotometry, UltravioletDrug Resistance, NeoplasmGuanidinesChromatography, High Pressure LiquidDoxorubicinPrednisoneProtein DenaturationDose-Response Relationship, DrugSpectrometry, FluorescenceVidarabineEtoposideSurface-Active AgentsIsotonic SolutionsDaunorubicinThermodynamicsChemistry, PharmaceuticalMolecular ConformationTemperatureModels, ChemicalP-GlycoproteinProtein Structure, SecondaryTime FactorsIdarubicinNeoplasm ProteinsAmsacrineIndicators and ReagentsChemistry, PhysicalPhysicochemical PhenomenaElectrochemistryRazoxaneTopoisomerase InhibitorsRemission InductionIntercalating AgentsPolymersTabletsDrug EvaluationMolecular Sequence DataTopotecanTaxoidsBuffersTreatment OutcomeNuclear Magnetic Resonance, BiomolecularSpectroscopy, Fourier Transform InfraredEstramustinePulse RadiolysisTrifluoroethanolDrug CarriersViscosityDrug Administration ScheduleSodium ChlorideCardiotoxinsProtein FoldingAmino Acid SequenceOphthalmic SolutionsCyclophosphamideDNALeukemia, MyeloidExcipientsSpectrum AnalysisOrgan Preservation SolutionsHypertonic SolutionsScattering, RadiationParticle SizeOxidation-ReductionIonsCell SurvivalChemistryProstatic NeoplasmsPotentiometryDialysis SolutionsDiffusionDosage FormsPeptidesDNA Topoisomerases, Type IIUreaProtein Binding